Steven B Black

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA, USA
    Expert Rev Vaccines 4:793-805. 2005
  2. ncbi Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old
    Simon J Hambidge
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    JAMA 296:1990-7. 2006
  3. ncbi Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose
    Nancy D Lin
    Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, MA, USA
    BMC Pediatr 6:31. 2006
  4. ncbi Postmarketing evaluation of the safety and effectiveness of varicella vaccine
    S Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 18:1041-6. 1999
  5. ncbi Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
    Steven Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 23:485-9. 2004
  6. ncbi A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 22:766-72. 2004
  7. ncbi Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent
    Steven B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Pediatr Infect Dis J 25:306-11. 2006
  8. ncbi Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 24:6163-71. 2006
  9. ncbi Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 24:S2-79-80. 2006
  10. ncbi Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 1607 Bayside, Oakland, CA 94612, USA
    Eur J Pediatr 161:S127-31. 2002

Detail Information

Publications35

  1. ncbi A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA, USA
    Expert Rev Vaccines 4:793-805. 2005
    ..In published studies, the safety, immunogenicity and effectiveness of this combination vaccine were comparable with those of separately administered vaccines, with the advantage of a simplified dosing schedule...
  2. ncbi Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old
    Simon J Hambidge
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    JAMA 296:1990-7. 2006
    ..Beginning with the winter season of 2004-2005, influenza vaccination has been recommended for all children 6 to 23 months old in the United States. However, its safety in young children has not been adequately studied in large populations...
  3. ncbi Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose
    Nancy D Lin
    Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, MA, USA
    BMC Pediatr 6:31. 2006
    ....
  4. ncbi Postmarketing evaluation of the safety and effectiveness of varicella vaccine
    S Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 18:1041-6. 1999
    ..The Oka strain of live attenuated varicella virus was licensed for use in healthy children in the United States in March, 1995. We report a postmarketing evaluation of the short term safety of this vaccine within Kaiser Permanente...
  5. ncbi Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
    Steven Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 23:485-9. 2004
    ..Secondary objectives included determination of the risk of pneumococcal infections in unvaccinated older children and adults in the same population and the impact of vaccine introduction on patterns of antimicrobial resistance...
  6. ncbi A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 22:766-72. 2004
    ..Following the licensure of this vaccine, we began a Phase IV safety evaluation in adults and in children over 2 years of age...
  7. ncbi Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent
    Steven B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Pediatr Infect Dis J 25:306-11. 2006
    ..Safety and immunogenicity data on the coadministration of the fourth dose of PCV7 with measles-mumps-rubella (MMR), varicella and Haemophilus influenzae type b (Hib) vaccines are limited...
  8. ncbi Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 24:6163-71. 2006
    ..The DTaP-IPV vaccine had no negative effect on the response to co-administered MMR vaccine, making it well-suited for use as a pre-school booster...
  9. ncbi Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 24:S2-79-80. 2006
    ..There was no evidence of any concomittant increase in pneumococcal disease caused by non-vaccine serotypes. High-level resistance of pneumococci to penicillin fell from a peak of 15% in year 2000 to 5% in the first half of 2003...
  10. ncbi Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 1607 Bayside, Oakland, CA 94612, USA
    Eur J Pediatr 161:S127-31. 2002
    ..Febrile illness was the only adverse event seen more frequently after vaccine administration than during a control period. CONCLUSION: the seven-valent conjugate vaccine is safe and effective for use in the general population...
  11. ncbi Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
    Steven B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:810-5. 2002
    ..To determine the effectiveness of the Wyeth heptavalent pneumococcal conjugate vaccine against clinical and radiograph-confirmed pneumonia in children...
  12. ncbi Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort
    Steven B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:568-9. 2002
    ..These children are now 10 to 12 years of age. We found no evidence that vaccination with Hib conjugate vaccine in infancy is associated with risk of diabetes later in life...
  13. ncbi Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group
    S Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 19:187-95. 2000
    ....
  14. ncbi Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente
    S Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaze 16th floor, Oakland, CA 94612, USA
    Vaccine 19:S83-6. 2000
    ..Vaccination of healthy infants would result in net savings for society if the vaccine cost less than $46 per dose, and net savings for the health care payer if the vaccine cost less than $18 per dose...
  15. ncbi Perspectives on the design and analysis of prelicensure trials: bridging the gap to postlicensure studies
    S Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Clin Infect Dis 33:S323-6. 2001
    ....
  16. ncbi Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
    S B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 20:1105-7. 2001
    ..To evaluate the impact of the introduction and routine use of seven valent pneumococcal conjugate vaccine on the epidemiology of invasive pneumococcal disease within the Northern California Kaiser Permanente (KP) population...
  17. ncbi Impact of the pneumococcal conjugate vaccine on otitis media
    Bruce Fireman
    Kaiser Permanente Division of Research and the Kaiser Permanente Vaccine Studies Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 22:10-6. 2003
    ..The heptavalent pneumococcal conjugate vaccine (PCV) is recommended for infants to protect against invasive disease, but its impact on otitis might also have public health importance...
  18. ncbi Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects
    G Thomas Ray
    Division of Research, Kaiser Permanente Medical Care Program Northern California Region, Oakland, CA 94612, USA
    Pediatr Infect Dis J 25:494-501. 2006
    ..Pneumococcal conjugate vaccine (PCV) has been in routine use in the United States for 5 years. Prior U.S. cost-effectiveness analyses have not taken into account the effect of the vaccine on nonvaccinated persons...
  19. ncbi Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine
    G Thomas Ray
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA 94611, USA
    Pediatr Infect Dis J 21:361-5. 2002
    ..Pneumococcal conjugate vaccine for infants has recently been found to be effective for prevention of meningitis, bacteremia, pneumonia and otitis media, but it is more costly than previously introduced vaccines...
  20. ncbi Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants
    Steven B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Am J Perinatol 21:333-9. 2004
    ..Hospitalizations for respiratory illness were uncommon in both vaccinees and nonvaccinees...
  21. ncbi Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children
    Henry R Shinefield
    Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:555-61. 2002
    ....
  22. ncbi Safety of the trivalent inactivated influenza vaccine among children: a population-based study
    Eric K France
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, USA
    Arch Pediatr Adolesc Med 158:1031-6. 2004
    ..To our knowledge, there are no published population-based studies on the safety of the inactivated trivalent influenza vaccine among children...
  23. ncbi Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
    Timo Vesikari
    University of Tampere Medical School, Tampere, Finland
    N Engl J Med 354:23-33. 2006
    ..The risk of intussusception was similar in vaccine and placebo recipients. (ClinicalTrials.gov number, NCT00090233.)..
  24. ncbi Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live)
    Henry H Bernstein
    Dartmouth Medical School, Children s Hospital at Dartmouth, Lebanon, New Hampshire, USA
    Pediatrics 119:e1299-305. 2007
    ..The objective of this study was to demonstrate that the immunogenicity and safety profiles of a refrigerator-stable formulation of ProQuad are similar to the recently licensed frozen formulation...
  25. ncbi Polio extraimmunization in children younger than 2 years after changes in immunization recommendations
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 111:296-301. 2003
    ..CONCLUSIONS: Poliovirus extraimmunization rates have fallen dramatically in association with the change-over to the all inactivated polio virus schedule...
  26. ncbi Childhood vaccinations and risk of asthma
    Frank Destefano
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 21:498-504. 2002
    ..The weak associations for Hib and hepatitis B vaccines seem to be at least partially accounted for by health care utilization or information bias...
  27. ncbi Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions
    Claire Anne Siegrist
    Center for Vaccinology and Neonatal Immunology, University of Geneva, Geneva, Switzerland
    Pediatr Infect Dis J 26:979-84. 2007
    ..To anticipate events that might be mistakenly assumed to be caused by immunization, their prevalence was monitored before vaccine introduction...
  28. ncbi Risk of anaphylaxis after vaccination of children and adolescents
    Kari Bohlke
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101 1448, USA
    Pediatrics 112:815-20. 2003
    ..To quantify the risk of anaphylaxis after vaccination of children and adolescents...
  29. ncbi A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination
    Thomas Verstraeten
    Epidemic Intelligence Service Program, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 112:e98-103. 2003
    ..We assessed the association of varicella breakthrough with asthma, steroids, age at varicella vaccination, and timing of measles-mumps-rubella (MMR) vaccination...
  30. ncbi Vaccinations and risk of central nervous system demyelinating diseases in adults
    Frank Destefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Neurol 60:504-9. 2003
    ..Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases...
  31. ncbi Hepatitis B vaccination among adolescents in 3 large health maintenance organizations
    Idalia M Gonzalez
    Epidemiology Program Office, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:929-34. 2002
    ..Little is known about the implementation of these recommendations in a managed care setting. The objective of this study was to determine the impact of ACIP recommendations on HB vaccination among adolescents in 3 managed care settings...
  32. ncbi Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study
    Onchee Yu
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 16:736-45. 2007
    ..To test the hypothesis that hepatitis B vaccine increases the risk of ATD, we conducted a case-control study, within the Vaccine Safety Datalink project...
  33. ncbi Compliance with national immunization guidelines for children younger than 2 years, 1996-1999
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 115:461-7. 2005
    ..6% of children were compliant with prevailing childhood immunization recommendations from 1996 to 1999. Efforts to improve compliance with guidelines are recommended, to optimize childhood infectious disease prevention...
  34. ncbi Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years
    Robert B Belshe
    Center for Vaccine Development, Saint Louis University School of Medicine, St Louis, MO 63110, USA
    Clin Infect Dis 39:920-7. 2004
    ....
  35. ncbi Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases
    Thomas Verstraeten
    Epidemic Intelligence Service Program, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 112:1039-48. 2003
    ..Conflicting results were found at different HMOs for certain outcomes. For resolving the conflicting findings, studies with uniform neurodevelopmental assessments of children with a range of cumulative thimerosal exposures are needed...